Literature DB >> 25080075

Kinetic resolution of profens by enantioselective esterification catalyzed by Candida antarctica and Candida rugosa lipases.

Adam Sikora1, Tomasz Siódmiak, Michał Piotr Marszałł.   

Abstract

Profens (2-arylpropionic acids) are known as one of the major nonsteroidal antiinflammatory drugs (NSAIDs) used in the treatment of inflammation associated with tissue injury. The inflammatory activity of profens is mainly due to their (S)-enantiomer, whereas they are commercially available not only as pure enantiomers, but as racemates as well. There are several methods widely used in order to obtain enantiomerically pure compounds, however, the kinetic resolution with the application of lipases as biocatalysts may have an added advantage in the production of optically pure active pharmaceutical ingredients, such as milder reaction conditions, reduced energy requirements, and production costs. The aim of this study was to compare the results described in the literature in the case of the influence of reaction medium, alcohol moiety, and reaction temperature on the catalytic activity of lipases from Candida antarctica and Candida rugosa.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  2-arylpropionic acid; Candida antarctica lipase; Candida rugosa lipase; Novozym 435; kinetic resolution

Mesh:

Substances:

Year:  2014        PMID: 25080075     DOI: 10.1002/chir.22362

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  2 in total

1.  High enantioselective Novozym 435-catalyzed esterification of (R,S)-flurbiprofen monitored with a chiral stationary phase.

Authors:  Tomasz Siódmiak; Debby Mangelings; Yvan Vander Heyden; Marta Ziegler-Borowska; Michał Piotr Marszałł
Journal:  Appl Biochem Biotechnol       Date:  2015-01-06       Impact factor: 2.926

2.  The effect of enzyme loading, alcohol/acid ratio and temperature on the enzymatic esterification of levulinic acid with methanol for methyl levulinate production: a kinetic study.

Authors:  Miaojia Song; Xiaohui Di; Yu Zhang; Yongming Sun; Zhongming Wang; Zhenhong Yuan; Ying Guo
Journal:  RSC Adv       Date:  2021-04-22       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.